GENinCode Predictive Genetics

GENinCode specializes in risk assessment and prediction of cardiovascular disease , thrombosis and familial hypercholesterolemia . Cardiovascular disease (CVD) is a broad disease classification including coronary artery disease such as angina and myocardial infarction often referred to as heart attack. CVD also includes stroke, heart failure, hypertension and other vascular heart diseases and is the leading cause of death and disability worldwide accounting for 1 in every 4 deaths in the United States. GENinCode provides advanced genomic technology, products and recommendations fully validated by our scientific and clinical team. Our goal is to provide doctors and health care practitioners with...

Genetic testing,precision medicine,familial hypercholesterolemia,thrombophilia,repeated pregnancy loss,thrombosis,cardiovascular risk,sudden cardiac death,familial cardiomiopathy,predictive genetics,and cardiovascular prevention

Genincode predictive genetics operates in the Biotechnology research industry.

Genincode predictive genetics's revenue is 1m - 10m

Genincode predictive genetics has 11 - 50 employees.